Restoring Iron Deficiency to Expand Blood Volume and Improve POTS

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2
SUMMARY

People with postural orthostatic tachycardia syndrome (POTS) often have low red blood cell volumes and low ferritin in their blood (a marker of iron storage in the body). The purpose of this pilot study is to investigate whether giving iron to people with POTS who have low ferritin levels will increase the red blood cell volume and improve POTS symptoms.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: f
View:

• Age 18-45 years old.

• Diagnosis of POTS, defined by a sustained heart rate increase of at least 30 bpm within 10 min of standing or head-up tilt (or absolute upright heart rate \>120 bpm), in the absence of orthostatic hypotension, and with at least 3 months of symptoms of orthostatic intolerance.

• Absence of other diseases or medications that can explain orthostatic tachycardia or symptoms.

• Serum ferritin \<50 ng/ml.

• Patients on fludrocortisone will be allowed to participate as long as they have been on the same dose for at least one month before enrollment and continue on the same dose throughout the study.

Locations
United States
Tennessee
Autonomic Dysfunction Center/ Vanderbilt University Medical Center
RECRUITING
Nashville
Contact Information
Primary
Megan Orillion, BSN, RN
autonomics@vumc.org
615-875-9405
Backup
Luis E Okamoto, MD
autonomics@vumc.org
615-936-6119
Time Frame
Start Date: 2025-10
Estimated Completion Date: 2026-10
Participants
Target number of participants: 12
Treatments
Experimental: Intravenous Iron Infusion
The Intravenous iron infusion will be administered according to standard clinical care.
Sponsors
Leads: Vanderbilt University Medical Center
Collaborators: Dysautonomia International

This content was sourced from clinicaltrials.gov

Similar Clinical Trials